Skip to main content
Skip to section navigation
Skip to footer
Stock Information
chevron_left
Back to CastleBiosciences.com
Overview
News & Events
keyboard_arrow_down
Press Releases
IR Events
Presentations
In The Media
Annual Meeting
Email Alerts
Company Info
keyboard_arrow_down
Company Profile
Executive Team
Annual Reports & Proxy
Contacts
FAQ
Financial Info
keyboard_arrow_down
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
keyboard_arrow_down
Quote & Chart
Historical Data
Analyst Coverage
SEC Filings
keyboard_arrow_down
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
keyboard_arrow_down
Governance Overview
Board of Directors
Board Committees
Governance Documents
Corporate Responsibility
Resources
keyboard_arrow_down
Scientific Evidence
Stock Information
chevron_left
Back to CastleBiosciences.com
Press Releases
News & Events
News & Events
Press Releases
IR Events
Presentations
In The Media
Annual Meeting
Email Alerts
Year
All Years
2026
2025
2024
2023
2022
2021
2020
2019
Category
All Releases
Financial Releases
Non-Financial Releases
Jul 24, 2019 9:38 pm EDT
Castle Biosciences Announces Pricing of Initial Public Offering
Previous Page
arrow_back
Page
1
…
Page
31
Page
32
Page
33
Page
34
Page
35
Page
36
Page
37
Page
38
Page
39
Page
40
Select a page
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
Page 25
Page 26
Page 27
Page 28
Page 29
Page 30
Page 31
Page 32
Page 33
Page 34
Page 35
Page 36
Page 37
Page 38
Page 39
Page 40
rss_feed
News RSS
email
Email Alerts
location_city
Company Profile
contact_page
Contacts
rss_feed
RSS News Feed
